 |
|
Carisoprodol as a Drug of Abuse
George S. Rust, MD, MPH;
Robert Hatch, MD, MPH;
John G. Gums, PharmD
Arch Fam Med. 1993;2(4):429-432.
Abstract
| |
Carisoprodol (available as Soma and in other commercial forms) is a commonly prescribed muscle relaxant. A small group of patients was recently discovered colluding to obtain the drug under false pretenses for the purposes of substance abuse. Animal and human studies have previously shown limited potential for tolerance or abuse, while the evidence for therapeutic efficacy is inadequate. There are two previous case reports of human carisoprodol abuse or dependence, one in which a patient showed signs of a true withdrawal syndrome. A third case involved a fatality linked to carisoprodol abuse. Data from the National Institute on Drug Abuse reveal that overdose and abuse of carisoprodol may be more common than previously suspected. Carisoprodol use should be limited to short-term treatment of acute musculoskeletal conditions involving significant muscle spasm. Suspicions of abuse should be raised by patients requesting the drug by name, "losing" prescriptions, using carisoprodol chronically, or denying the efficacy of less mind-altering alternatives.
Author Affiliations
From the Department of Family Medicine, Morehouse School of Medicine, Atlanta, Ga (Dr Rust), and the Department of Community Health and Family Medicine, University of Florida School of Medicine, Gainesville (Drs Hatch and Gums).
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Carisoprodol-Mediated Modulation of GABAA Receptors: In Vitro and in Vivo Studies
Gonzalez et al.
J. Pharmacol. Exp. Ther. 2009;329:827-837.
ABSTRACT
| FULL TEXT
Tizanidine in the management of spasticity and musculoskeletal complaints in the palliative care population
Smith and Barton
AM J HOSP PALLIAT CARE 2000;17:50-58.
ABSTRACT
Carisoprodol Should Be a Controlled Substance
Dougherty
Arch Fam Med 1995;4:582-582.
ABSTRACT
Should Carisoprodol Be a Controlled Substance?
Chop
Arch Fam Med 1993;2:911-911.
ABSTRACT
|
